InVia Fertility Specialists Adds INVOCELL®, An Innovative Option Used in Fertility Treatment, to its Reproductive Health Services

• InVia Fertility Specialists aims to expand fertility options and help improve access to care with the addition of the INVOCELL Intravaginal Culture (IVC) System
• The INVOCELL IVC System is a cost-conscious option that uses a woman’s own body as an incubator during fertilization and early embryo development

Hoffman Estates, IL – October 10, 2019 – InVia Fertility Specialists announced today it now offers the INVOCELL Intravaginal Culture (IVC) System as part of its scope of reproductive health services. The INVOCELL IVC System, the first-of-its-kind, which comprises the INVOCELL Culture Device and Retention Device,¹ is the only IVC system cleared by the Food and Drug Administration.

“We are pleased to add INVOCELL to our current reproductive health offering as an innovative option for patients struggling with infertility,” said Vishvanath Karande, MD. “Statistics show that over 1.4 million women in the United States may benefit from advanced fertility treatment, yet only an estimated 130,000 of them begin such treatment.² As a cost-conscious option, we believe that INVOCELL will help us improve access to care for those hoping to be parents.”

INVOCELL is a patented medical device used in the treatment of infertility that enables egg fertilization and early embryo development to take place in a woman's body. The eggs are retrieved from a woman’s ovaries and placed in the INVOCELL system with sperm. INVOCELL is then placed in the woman’s body to allow fertilization and incubation to occur, making the patient an even greater part of the process. To learn more, visit www.INVOCELL.com.

About INVOCELL

INVOCELL Intravaginal Culture System contains the INVOCELL Culture Device and INVOCELL Retention Device. The Culture Device is indicated for use in preparing, holding, and transferring human gametes or embryos during In Vitro Fertilization/Intravaginal Culture (IVF/IVC) and Intra-cytoplasmic Sperm Injection Fertilization/Intravaginal Culture (ICSI/IVC). The Retention Device is used during the incubation period to aid in holding the Culture Device in the vagina. The Culture and Retention Devices are not indicated for periods of use exceeding 72 hours.

www.INVOCELL.com                  

Important Safety Information:

• Do not use the Culture or Retention devices if you are unable to tolerate having a device placed within your vagina.
• Do not use the Culture Device if you are sensitive to medical grade silicone or polystyrene or if you have a severe case of vaginitis or a history of toxic shock syndrome. Tell your doctor if you have had any recent pelvic surgery.
• Avoid any activity such as sexual intercourse, strenuous physical activity, swimming, bathing in a tub (a shower is permissible), use of a douche, sauna, or any other activity that may alter the temperature of the vaginal cavity and avoid handling or removing the Culture and Retention Devices while in place.
• Your doctor should explain to you what to do if the Culture and Retention Device should shift in the vagina or fall out. Call your doctor right away should this occur.

Your doctor will determine if this product is right for you and will provide you with more detailed information about the risks and benefits associated with using this device. Always follow your doctor’s instructions. Contact your doctor immediately if you have any questions or concerns before, during, or after treatment.

Please see the INVOCELL Patient Information and Instructions for Use at www.INVOCELL.com.

References:

1. Instructions for Use: The INVOCELL Intravaginal Culture System
2. Fertility Dynamics, an independent data analytics, research and strategic advisory firm based in Washington, DC

# # #

For more information, please contact: InVia Fertility Specialists at 847-884-8884

INVO/634/2019/US

INVOCELL is a registered trademark of INVO Bioscience.